- Trials with a EudraCT protocol (4,800)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
4,800 result(s) found for: F Test.
Displaying page 1 of 240.
EudraCT Number: 2007-005716-64 | Sponsor Protocol Number: 112233020781 | Start Date*: 2008-08-28 |
Sponsor Name:Universitätsklinik für Psychiatrie des Kindes- und Jugendalters, AKH Wien, Medizinische Universität | ||
Full Title: Elevated elimination rates of quetiapine in adolescent patients with schizophrenia (ICD 10: F 20.-), bipolar affective disorder (ICD 10: F 31.-), disorders in impulse control with current PTSD (ICD... | ||
Medical condition: schizophrenia (ICD 10: F 20.-), bipolar affective disorder (ICD 10: F 31.-), disorders of impulse control with current PTSD (ICD 10: F 43.1) or personality disorder (ICD 10: F 60.-). | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-001174-33 | Sponsor Protocol Number: 28612 | Start Date*: 2008-12-30 | |||||||||||
Sponsor Name:Merck Serono International S.A., A branch of Laboratoires Serono S.A. | |||||||||||||
Full Title: A mulitnational, multicenter, exploratory pharmacogenomics trial to test the importance of identified genetic markers, and potentially identify new markers of various ovarian responses to GONAL-f® ... | |||||||||||||
Medical condition: Females undergoing assisted reproductive technology (ART), in vitro fertilisation (IVF) or intra cytoplasmic sperm injection (ICSI) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) GB (Prematurely Ended) AT (Prematurely Ended) FR (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000436-62 | Sponsor Protocol Number: GS-US-380-4547 | Start Date*: 2021-02-12 |
Sponsor Name:Gilead Sciences, Inc | ||
Full Title: A Phase 1, Single-Dose, Cross-Over Study Evaluating the Relative Bioavailability and Food Effect of a Pediatric Tablet for Oral Suspension of Bictegravir/Emtricitabine/Tenofovir Alafenamide and the... | ||
Medical condition: Human Immunodeficiency Virus (HIV-1) Infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2009-017415-16 | Sponsor Protocol Number: AFCT-14/2009 | Start Date*: 2010-07-26 |
Sponsor Name:Dr. August Wolff GmbH & Co KG Arzneimittel | ||
Full Title: A Phase III, single-center, randomized, double-blind, parallel group, placebo-controlled study of Alpicort F in the treatment of chemotherapy induced alopecia in women | ||
Medical condition: Chemotherapy induced alopecia in women | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000926-79 | Sponsor Protocol Number: GS-US-380-4458 | Start Date*: 2018-08-07 | ||||||||||||||||
Sponsor Name:Gilead Sciences, Inc. | ||||||||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide versus Dolutegravir + Emtricitabine/Tenofo... | ||||||||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV-1) Infection Hepatitis B Virus | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) ES (Restarted) GR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000737-40 | Sponsor Protocol Number: BAY12-8039/11826 | Start Date*: 2012-02-20 |
Sponsor Name:Bayer HealthCare Pharmaceuticals | ||
Full Title: Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients | ||
Medical condition: No medical condition specified as the purpose of this study is to describe the pharmacokinetics of moxifloxacin in children for future antibiotic treatment. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2010-024044-15 | Sponsor Protocol Number: BMS747158-301 | Start Date*: 2011-06-08 | |||||||||||
Sponsor Name:Lantheus Medical Imaging, Inc. | |||||||||||||
Full Title: A Phase 3, Open-Label, Multicenter Study for the Assessment of Myocardial Perfusion using Positron Emission Tomography (PET) Imaging of Flurpiridaz F 18 Injection in Patients with Suspected or Know... | |||||||||||||
Medical condition: Assessment of myocardial perfusion using Positron Emission Tomography (PET) Imaging of Flurpiridaz F 18 Injection in patients with suspected or known coronary artery disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002678-29 | Sponsor Protocol Number: BMS747158-302 | Start Date*: 2013-02-21 | |||||||||||
Sponsor Name:Lantheus Medical Imaging, Inc. | |||||||||||||
Full Title: A Phase 3, Open-Label, Multicenter Study for the Assessment of Myocardial Perfusion using Positron Emission Tomography (PET) Imaging of Flurpiridaz F 18 Injection in Patients with Suspected or Know... | |||||||||||||
Medical condition: Assessment of myocardial perfusion using Positron Emission Tomography (PET) Imaging of Flurpiridaz F 18 Injection in patients with suspected or known coronary artery disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Temporarily Halted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000308-17 | Sponsor Protocol Number: GS-US-380-4030 | Start Date*: 2017-07-05 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching from a Regimen of Dolutegravir and Either Emtricitabine/Tenofovir Alafenamide or Emtricitabine/Tenofovir D... | |||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV-1) Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006443-50 | Sponsor Protocol Number: AGO/2007/013 | Start Date*: 2007-12-12 |
Sponsor Name:University Hospital Ghent | ||
Full Title: Prospective, randomized trial to evaluate the administration of 2 different doses of recombinant FSH to patients with age depended insufficient ovarian response during IVF/ICSI | ||
Medical condition: Patients with age dependend insufficient ovarian response during IVF/ICSI | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020223-44 | Sponsor Protocol Number: FinalVersion | Start Date*: 2010-08-03 |
Sponsor Name:Medizinische Universität Wien, Univ.Klinik f.Radiodiagnostik | ||
Full Title: (18)F-FDG PET/CT in patients with idiopathic interstitial pneumonias: correlation of tracer uptake and histological findings, and texture-based recognition of usual interstitial pneumonia | ||
Medical condition: Interstitial lung disease of unknown etiology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2010-019287-37 | Sponsor Protocol Number: FIN3001 | Start Date*: 2010-08-24 |
Sponsor Name:Finox AG | ||
Full Title: A phase III assessor-blinded randomised parallel group multi-centre study to compare efficacy adn safety of two r-hFSH formulations (AFOLIA and Gonal-f®) in women for assisted reproductive treatment | ||
Medical condition: Stimulation of multifollicular develoment in patients undergoing assisted reproductivet treatment | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) AT (Completed) ES (Completed) GB (Prematurely Ended) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002345-39 | Sponsor Protocol Number: GS-US-380-1474 | Start Date*: 2016-06-29 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the GS-9883/Emtricitabine/Tenofovir Alafenamide (GS-9883/F/TAF) Fixed Dose Combination (FDC) in HIV-1 Infect... | |||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV-1) Infection | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002735-27 | Sponsor Protocol Number: R30-05-01 | Start Date*: 2005-09-19 |
Sponsor Name:Fidia Farmaceutici SpA | ||
Full Title: A multicentre study to assess the safety and efficacy of sodium hyaluronate (Hyalgan-F) produced by fermentation in knee psteoarthritis. | ||
Medical condition: Knee oasteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: | |
Trial protocol: LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-001259-22 | Sponsor Protocol Number: 28613 | Start Date*: 2008-09-01 | |||||||||||
Sponsor Name:Merck Serono International S.A. | |||||||||||||
Full Title: A phase IV prospective, multicentre, randomized, open-label trial to assess the efficacy and safety of GONAL f® at a dose based on subject baseline characteristics determined according to the CONSO... | |||||||||||||
Medical condition: Ovarian stimulation in women undergoing assisted reproductive technology | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) SE (Completed) ES (Completed) DE (Completed) DK (Completed) GB (Completed) IT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001948-39 | Sponsor Protocol Number: 01042008 | Start Date*: 2008-06-27 |
Sponsor Name:HANNU KOKKI | ||
Full Title: PAMOL F FARMAKOKINETIIKKA MAHAKIRURGISILLA POTILAILLA - 2 | ||
Medical condition: Tutkimukseen otetaan 15 perustervettä mahakirurgiseen toimenpiteeseen tulevaa aikuispotilasta | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003428-61 | Sponsor Protocol Number: GS-US-380-4449 | Start Date*: 2018-04-06 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 3b, Multicenter, Open-Label Study to Evaluate Switching from an Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed-Dose Combination Regimen or a Tenofovir Disoproxil Fumarate... | |||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV-1) Infection | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) ES (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002565-17 | Sponsor Protocol Number: WODDOL | Start Date*: 2021-12-02 | |||||||||||
Sponsor Name:FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE | |||||||||||||
Full Title: Multi-center study to evaluate virological efficacy, safety tolerability, drug exposure and patients’ reported outcomes over 48 weeks following randomization to 2-drug therapy with DTG/3TC FDC or c... | |||||||||||||
Medical condition: HIV-1-infected adult women of >18 years of age, without previous virologic failure, currently receiving an effective (HIV-RNA < 50 copies/ml) triple-drug cART, containing tenofovir (TAF or TDF) in ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-005011-14 | Sponsor Protocol Number: GE-265-303 | Start Date*: 2018-09-03 | |||||||||||
Sponsor Name:GE Healthcare Ltd. and its Affiliates | |||||||||||||
Full Title: A Phase 3, Open-Label, Multicentre Study of Flurpiridaz (F 18) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coro... | |||||||||||||
Medical condition: Assessment of myocardial perfusion using Positron Emission Tomography (PET) imaging of Flurpiridaz (F 18) Injection in patients with suspected coronary artery disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) NL (Ongoing) DE (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004908-20 | Sponsor Protocol Number: PARAMRI | Start Date*: 2013-12-23 |
Sponsor Name:UZ Brussel [...] | ||
Full Title: Cerebral effect of paracetamol measured by f-MRI | ||
Medical condition: healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.